Scientist taking sample using a pipette

About Us

Wren Therapeutics is a spin-off company from the University of Cambridge (UK) and Lund University (Sweden) focussed on protein misfolding diseases. Wren Therapeutics is advancing an entirely novel approach to address this class of diseases, based on decades of research from its scientific founders focused on the chemical kinetics of the protein misfolding process.

Our mission

Wren Therapeutics is dedicated to eliminating protein misfolding diseases by discovering and developing new therapeutics using Wren’s unique networks kinetics drug discovery platform. As a result, Wren can radically advance drug discovery in this class of diseases that will change the course of life for millions of patients globally suffering from these debilitating and increasingly common medical disorders.

Our history

Founded by world-renowned scientists based on three decades of symbolic research.

Our founders

Our scientific founders are true pioneers in the field of protein misfolding diseases.

Our board

Meet the business leaders bringing together their experiences of drug discovery, drug development, regulatory and commercialisation.

Our team

Wren has brought together a highly interdisciplinary and international team with deep scientific, drug development and business expertise.

Novel technology tackling complex problems

See how our technology and kinetics-based approach is changing the future of science.

Our unique approach